← Back to Search

One-Legged vs Two-Legged Cycle Training for Idiopathic Pulmonary Fibrosis

N/A

Recruiting

Led By Roger S Goldstein

Research Sponsored by West Park Healthcare Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Confirmed idiopathic pulmonary fibrosis

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline at discharge from 8 weeks of pulmonary rehabilitation

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare the effects of one-legged versus two-legged exercise training in patients with idiopathic pulmonary fibrosis.

Who is the study for?

This trial is for stable patients with confirmed idiopathic pulmonary fibrosis who are enrolled in a pulmonary rehab program. It's not suitable for those who've had a recent exacerbation, finished rehab within the last 6 months, or have other health issues that could make rehab unsafe.

What is being tested?

The study tests if exercising one leg at a time can improve endurance more than the usual two-leg cycling for people with IPF. The idea is to reduce breathing demand during exercise by working fewer muscles simultaneously.

What are the potential side effects?

While specific side effects aren't listed, exercise interventions like these may cause muscle soreness, fatigue, and shortness of breath especially in individuals with lung conditions such as IPF.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with idiopathic pulmonary fibrosis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline at discharge from 8 weeks of pulmonary rehabilitation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline at discharge from 8 weeks of pulmonary rehabilitation

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at discharge from 8 weeks of pulmonary rehabilitation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Cycle exercise endurance time

Secondary study objectives

health-related quality of life

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: intervention -1-leg cycle trainingExperimental Treatment1 Intervention

Primary aerobic training component one-legged, partitioned, cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity one-legged exercise progressing to continuous duration of the target duration of 15 min for each leg and then restarting the cycle at a higher intensity.

Group II: usual care - 2-leg cycle trainingActive Control1 Intervention

Primary aerobic training component conventional two-legged cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity exercise progressing to continuous duration of 30 min and then restarting the cycle at a higher intensity.

0 / 1Eligibility criteria met